We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$501M
AUM Growth
-$11.6M
Cap. Flow
-$28.1M
Cap. Flow %
-5.6%
Top 10 Hldgs %
38.82%
Holding
117
New
8
Increased
26
Reduced
58
Closed
2

Top Sells

Rank Stock Value
1
GM icon
General Motors
GM
+$10.7M
2
WMT icon
Walmart Inc
WMT
+$9.33M
3
GSK icon
GSK
GSK
+$3.98M
4
TEL icon
TE Connectivity
TEL
+$2.91M
5
LNN icon
Lindsay Corp
LNN
+$2.77M

Sector Composition

Rank Sector Weight
1 Healthcare 24.73%
2 Industrials 20.6%
3 Technology 19.27%
4 Energy 10.71%
5 Utilities 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
1
Emerson Electric
EMR
$86.6B
$29.2M 5.83%
419,411
+54,410
+15% +$3.53M
XOM icon
2
ExxonMobil
XOM
$644B
$27.4M 5.47%
327,982
+11,941
+4% +$988K
JNJ icon
3
Johnson & Johnson
JNJ
$646B
$25.9M 5.16%
185,211
-2,010
-1% -$280K
GLW icon
4
Corning
GLW
$128B
$22.4M 4.47%
701,095
-2,538
-0.4% -$79.9K
SLB icon
5
SLB Ltd
SLB
$85.1B
$16.7M 3.34%
248,143
+19,669
+9% +$1.27M
PFE icon
6
Pfizer
PFE
$159B
$16.4M 3.28%
477,991
-7,681
-2% -$262K
INTC icon
7
Intel
INTC
$473B
$15.3M 3.06%
332,305
-3,510
-1% -$153K
ABT icon
8
Abbott
ABT
$195B
$15.3M 3.05%
267,992
-4,040
-1% -$224K
NVS icon
9
Novartis
NVS
$292B
$13.3M 2.65%
176,739
+288
+0.2% +$21.7K
GVA icon
10
Granite Construction
GVA
$5.44B
$12.5M 2.5%
197,815
-33,894
-15% -$2.12M
MRK icon
11
Merck
MRK
$366B
$11.5M 2.29%
213,968
-3,145
-1% -$174K
LNN icon
12
Lindsay Corp
LNN
$1.16B
$10.6M 2.12%
120,706
-30,485
-20% -$2.77M
IBM icon
13
IBM
IBM
$222B
$10.3M 2.05%
70,122
+147
+0.2% +$21.4K
TEL icon
14
TE Connectivity
TEL
$58.7B
$9.35M 1.87%
98,393
-31,648
-24% -$2.91M
GXP
15
DELISTED
Great Plains Energy Incorporated
GXP
$9.16M 1.83%
284,178
-3,966
-1% -$130K
TT icon
16
Trane Technologies
TT
$98.8B
$8.88M 1.77%
99,566
-1,438
-1% -$127K
MSFT icon
17
Microsoft
MSFT
$3.81T
$8.81M 1.76%
102,955
-1,350
-1% -$111K
HON icon
18
Honeywell
HON
$68.9B
$8.68M 1.73%
62,653
-1,120
-2% -$150K
COP icon
19
ConocoPhillips
COP
$157B
$8.66M 1.73%
157,750
-3,200
-2% -$165K
WTS icon
20
Watts Water Technologies
WTS
$12.2B
$8.53M 1.7%
112,324
-1,567
-1% -$112K
OGE icon
21
OGE Energy
OGE
$9.45B
$8.29M 1.65%
251,834
+47,568
+23% +$1.68M
BMY icon
22
Bristol-Myers Squibb
BMY
$136B
$8.22M 1.64%
134,226
+820
+0.6% +$51.3K
BCE icon
23
BCE
BCE
$21.9B
$7.97M 1.59%
165,965
+200
+0.1% +$9.52K
MDU icon
24
MDU Resources
MDU
$4.16B
$7.46M 1.49%
729,769
+61,760
+9% +$633K
LGTY
25
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$7.27M 1.45%
625,287
-11,067
-2% -$134K

Similar funds

John G. Ullman & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, John G. Ullman & Associates held 117 positions worth $501M, down 2.3% from $513M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

John G. Ullman & Associates withdrew a net $28.1M in Q4 2017, closing 2 positions and reducing 58 holdings. Its most notable exit was Xylem, an estimated $2.37M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Industrials and Technology.

Against the trend, John G. Ullman & Associates opened a new position in Archer Daniels Midland worth $3.68M.

  • John G. Ullman & Associates's largest Q4 2017 buy was Archer Daniels Midland: 91,750 shares worth $3.68M.
  • John G. Ullman & Associates added most to Emerson Electric in Q4 2017, an estimated $3.53M increase.
  • John G. Ullman & Associates's biggest Q4 2017 reduction was General Motors, cutting an estimated $10.7M.
  • John G. Ullman & Associates fully exited Xylem in Q4 2017, selling an estimated $2.37M.
  • John G. Ullman & Associates's ten largest holdings make up 39% of its $501M portfolio in Q4 2017.
  • John G. Ullman & Associates opened 8 new positions and closed 2 in Q4 2017.
  • John G. Ullman & Associates's portfolio value fell 2.3% quarter-over-quarter to $501M.

Based on John G. Ullman & Associates's 13F filing for Q4 2017, filed 31 Jan 2018.